Effect on metabolic bone disease markers in the neonatal intensive care unit with implementation of a practice guideline.

Objectives: To determine the effect of implementing a 2015 policy for the screening, prevention, and management of metabolic bone disease for very low birth weight (VLBW) infants in two Level IV NICUs.

Study Design: Retrospective cohort study of VLBW infants in the 2 years prior to (2013-2014) and after (2016-2017) policy implementation.

Results: We identified 316 VLBW infants in 2013-2014 and 292 in 2016-2017 who met study criteria.